CHEMOTHERAPY-INDUCED ALOPECIA

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SHAHBAL S.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: International Journal of Hematology-Oncology and Stem Cell Research Year:2009 | Volume:3 | Issue:4 (SUPPL 1) Page(s): 31-32

Download Full-Text

View:

435

Download:

Cites:

Information Journal Paper

Title

CHEMOTHERAPY-INDUCED ALOPECIA

Author(s)

SHAHBAL S.

Keywords

CHEMOTHERAPY

ALOPECIA

Abstract

Hair loss is a transient but often psychologically devastating consequence of cancer CHEMOTHERAPY. A wide range of CHEMOTHERAPY agents can affect the growing cells of the hair follicle. The frequency and severity of ALOPECIA varies depending upon the specific CHEMOTHERAPY agent or combination regimen administered the dosage of drugs, and the treatment schedule. The majority of CHEMOTHERAPY-induced ALOPECIA is reversible once therapy is discontinued, with the possible exception of the epidermal growth factor receptor (EGFR) inhibitors.All patients who will receive CHEMOTHERAPY that may result in ALOPECIA should be informed of the likely side effect of hair loss. Options such as head wraps, hats, or wigs should be discussed in advance so that the patient can be more physically and emotionally prepared.Although scalp protection through cooling or tourniquet has been reported to minimize delivery of chemotherapeutic agents to the scalp thereby potentially decreasing the risk of hair loss, case reports of cutaneous metastases or spread in these settings prevent general recommendation for their use. Because CHEMOTHERAPY-associated hair loss is transient and completely reversible after cessation of therapy, adequate counseling and psychological support before and during therapy should take precedence over the use of such devices.Currently there are no available pharmacologic interventions that have been shown to decrease the risk of CHEMOTHERAPY-induced ALOPECIA. Although minoxidil has not shown efficacy in preventing CHEMOTHERAPY induced ALOPECIA, the use of minoxidil during the period of regrowth may help to minimize hair follicle miniaturization in patients at risk for androgenetic ALOPECIA.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

SHAHBAL, S.. (2009). CHEMOTHERAPY-INDUCED ALOPECIA. INTERNATIONAL JOURNAL OF HEMATOLOGY-ONCOLOGY AND STEM CELL RESEARCH (IJHOSCR), 3(4 (SUPPL 1)), 31-32. SID. https://sid.ir/paper/313327/en

Vancouver: Copy

SHAHBAL S.. CHEMOTHERAPY-INDUCED ALOPECIA. INTERNATIONAL JOURNAL OF HEMATOLOGY-ONCOLOGY AND STEM CELL RESEARCH (IJHOSCR)[Internet]. 2009;3(4 (SUPPL 1)):31-32. Available from: https://sid.ir/paper/313327/en

IEEE: Copy

S. SHAHBAL, “CHEMOTHERAPY-INDUCED ALOPECIA,” INTERNATIONAL JOURNAL OF HEMATOLOGY-ONCOLOGY AND STEM CELL RESEARCH (IJHOSCR), vol. 3, no. 4 (SUPPL 1), pp. 31–32, 2009, [Online]. Available: https://sid.ir/paper/313327/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops